Close

MYOS RENS Tech (MYOS) Announces Research Agreement With University Of California, Berkeley To Study Effects Of Fortetropin

December 6, 2017 6:08 AM EST Send to a Friend
MYOS RENS Technology Inc. (NASDAQ: MYOS), has entered into a research agreement with the University of California, Berkeley's Department of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login